test-nav-cat
Nov
20

PPAR’s as critical regulators of metabolism

Prof Roden, Germany explains why PPAR’s are interesting therapeutic targets not only...

Nov
20

The changing global epidemiology of hepatocellular carcinoma

Hepatocellular carcinoma is the fifth and ninth most commonly diagnosed cancer in...

Nov
20

Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes

Trimethylamine N-oxide (TMAO), choline and betaine serum levels have been associated with...

Nov
11

Non-alcoholic fatty liver disease and alcohol-related liver disease: Two intertwined entities

In their review, F. Idalsoaga et al. aim to summarise current data...

Nov
11

Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease

Lanifibranor is a moderately potent and well-balanced modulator of the three PPAR...

Nov
11

PPAR’s as critical regulators of metabolism

Prof Roden, Germany explains why PPAR’s are interesting therapeutic targets not only...

The PanNASH initiative is supported by
logo (1)